Melissa L. Cullimore

Infants Admitted to US Intensive Care Units for RSV Infection During the 2022 Seasonal Peak

Extracorporeal Membrane Oxygenation Characteristics and Outcomes in Children and Adolescents With COVID-19 or Multisystem Inflammatory Syndrome Admitted to U.S. ICUs*

Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants

BNT162b2 mRNA Vaccination Against Coronavirus Disease 2019 is Associated With a Decreased Likelihood of Multisystem Inflammatory Syndrome in Children Aged 5–18 Years—United States, July 2021 – April 2022

Health Impairments in Children and Adolescents After Hospitalization for Acute COVID-19 or MIS-C

NFKB2 haploinsufficiency identified via screening for IFN-α2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2–related complications

Measurement of Severe Acute Respiratory Syndrome Coronavirus 2 Antigens in Plasma of Pediatric Patients With Acute Coronavirus Disease 2019 or Multisystem Inflammatory Syndrome in Children Using an Ultrasensitive and Quantitative Immunoassay

Changes in Distribution of Severe Neurologic Involvement in US Pediatric Inpatients With COVID-19 or Multisystem Inflammatory Syndrome in Children in 2021 vs 2020

Life-Threatening Complications of Influenza vs Coronavirus Disease 2019 (COVID-19) in US Children

<i>DDX58</i> Is Associated With Susceptibility to Severe Influenza Virus Infection in Children and Adolescents

Association of Asthma With Treatments and Outcomes in Children With Critical Influenza

Tachyarrhythmias During Hospitalization for COVID‐19 or Multisystem Inflammatory Syndrome in Children and Adolescents

Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome

Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12–18 Years — United States, June–September 2021

Vaccine Effectiveness Against Life-Threatening Influenza Illness in US Children

Paediatric acute respiratory distress syndrome incidence and epidemiology (PARDIE): an international, observational study